XADAGO

Peak

safinamide mesylate

NDAORALTABLET
Approved
Mar 2017
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Mar 21, 2031
61 months away
Patent Expiry
Mar 21, 2031

Patent Records (3)

Patent #ExpiryTypeUse Code
8278485
Jun 8, 2027
Substance
U-1993
8076515
Dec 10, 2028
SubstanceProduct
U-1993
8283380
Mar 21, 2031
U-1993
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers